![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07B 59/001 | (2013.01) |
C07B 59/00 | (2006.01) | ||
A61K 51/00 | (2006.01) | ||
C07C 275/30 | (2013.01) | ||
C07C 311/19 | (2013.01) | ||
C07D 213/38 | (2013.01) | ||
C07C 275/16 | (2013.01) | ||
C07C 275/24 | (2013.01) | ||
A61P 21/00 | (2018.01) | ||
A61P 21/02 | (2018.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 25/02 | (2018.01) | ||
A61P 25/04 | (2018.01) | ||
A61P 25/18 | (2018.01) | ||
A61P 25/28 | (2018.01) | ||
A61P 29/00 | (2018.01) | ||
A61P 35/00 | (2018.01) |
(11) | Number of the document | 3699162 |
(13) | Kind of document | T |
(96) | European patent application number | 19214298.2 |
Date of filing the European patent application | 2007-11-07 | |
(97) | Date of publication of the European application | 2020-08-26 |
(45) | Date of publication and mention of the grant of the patent | 2022-06-29 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
857490 P | 2006-11-08 | US | |
878678 P | 2007-01-05 | US |
(72) |
BABICH, John W. , US
ZIMMERMAN, Craig N. , US
MARESCA, Kevin P. , US
|
(73) |
Molecular Insight Pharmaceuticals, Inc. ,
One World Trade Center
47th Floor, Suite J, New York, NY 10007,
US
|
(54) | HETERODIMERS OF GLUTAMIC ACID |
HETERODIMERS OF GLUTAMIC ACID |